Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Document:EU ; GBR MDCG 2020-10/1 - Safety reporting in clinical investigations of medical devices 2020: Difference between revisions

From GxPlex

Jump to: navigation, search
← Older edit
Migrate to Template:DocumentData for PageForms (GxPlexBot)
Remove static References table, superseded by live #ask in Template:DocumentData (GxPlexBot)
 
Line 21: Line 21:
|contributors=
|contributors=
}}
}}
<noinclude>
== References ==
{| class="wikitable"
! Reference !! Scope !! Document part !! Language !! Preview
|-
| [[Reference:EU ; GBR MDCG 2020-10/1 - Safety reporting in clinical investigations of medical devices 2020 8.2-001]] || MD || 8.2 || EN || 8 Reporting timelines [...] 8.2 Report by the investigator to the sponsor The sponsor shall implement and maintain a system to ensure that the reporting of the reportable events as defined under ...
|-
| [[Reference:EU ; GBR MDCG 2020-10/1 - Safety reporting in clinical investigations of medical devices 2020 8.2-002]] || MD || 8.2 || EN || 8 Reporting timelines [...] 8.2 Report by the investigator to the sponsor The sponsor shall implement and maintain a system to ensure that the reporting of the reportable events as defined under ...
|-
| [[Reference:EU ; GBR MDCG 2020-10/1 - Safety reporting in clinical investigations of medical devices 2020 8-001]] || MD || 8 || EN || 8 Reporting timelines 8.1 Report by sponsor to NCAs. The sponsor must report to all NCAs where the clinical investigation is authorised to start: • For all reportable events as described in section 5 ...
|-
| [[Reference:EU ; GBR MDCG 2020-10/1 - Safety reporting in clinical investigations of medical devices 2020 8-002]] || MD || 8 || EN || 8 Reporting timelines 8.1 Report by sponsor to NCAs. The sponsor must report to all NCAs where the clinical investigation is authorised to start: • For all reportable events as described in section 5 ...
|}
</noinclude>

Latest revision as of 14:15, 16 July 2026


Document information
Reference EU ; GBR MDCG 2020-10/1

- Safety reporting in clinical investigations of medical devices 2020

Validity area EU ; GBR
Scope(s) MD
Document name MDCG 2020-10/1

- Safety reporting in clinical investigations of medical devices

Version / Revision 2020
Status Current
Document type Official recommendation
Language(s) EN
Description MDCG 2020-10/1 Rev 1

Safety reporting in clinical investigations of medical devices under the Regulation (EU) 2017/745

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors

References

 ScopeDocument partLanguagePreview
EU ; GBR MDCG 2020-10/1 - Safety reporting in clinical investigations of medical devices 2020 8-001MD8EN8 Reporting timelines

8.1 Report by sponsor to NCAs. The sponsor must report to all NCAs where the clinical investigation is authorised to start:

• Fo…
EU ; GBR MDCG 2020-10/1 - Safety reporting in clinical investigations of medical devices 2020 8-002MD8EN8 Reporting timelines

8.1 Report by sponsor to NCAs. The sponsor must report to all NCAs where the clinical investigation is authorised to start:

• Fo…
EU ; GBR MDCG 2020-10/1 - Safety reporting in clinical investigations of medical devices 2020 8.2-001MD8.2EN8 Reporting timelines

[...] 8.2 Report by the investigator to the sponsor

The sponsor shall implement and maintain a system to ensure that the reporti…
EU ; GBR MDCG 2020-10/1 - Safety reporting in clinical investigations of medical devices 2020 8.2-002MD8.2EN8 Reporting timelines

[...] 8.2 Report by the investigator to the sponsor

The sponsor shall implement and maintain a system to ensure that the reporti…
Retrieved from "https://gxplex.org/index.php?title=Document:EU_;_GBR_MDCG_2020-10/1_-_Safety_reporting_in_clinical_investigations_of_medical_devices_2020&oldid=20350"